Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
| Catalog No. | Product Name | Size | List Price (US$) | Quantity |
|---|
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Background Information:
XL184 (Cabozantinib) is an orally active, multitargeted inhibitor of tumor growth, metastasis and angiogenesis, simultaneously targeting c-MET, RET and VEGFR2 with IC50s at low nM.
Reference:
1. Kurzrock, R., et al., J Clin Oncol, 2011 Jul 1; 29(9): 2662-6.
2. Durante, C., et al., Expert Opin Investig Drugs, 2011 May; 20 (3): 403-413.
3. You WK, et al. Cancer Res, 2011, 71(14), 4758-4768.
APIM050263: XL184 (CABOZANTINIB) (FREE BASE)
CAS No.: 849217-68-1.
Molecular Formula: C28H24FN3O5.
Molecular Weight: 501.5.
Purity: >99.5% (HPLC at 214 and 254 nm).
QC: 1HNMR, HPLC/MS, and Quantitative Elemental Analysis Report.
Solubility: Soluble in DMSO.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.
Copyright © 2009-2022 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.